GluN2C selective inhibition is a target to develop new antiepileptic compounds. Gataullina S, Galvani G, Touchet S, Nous C, et al. Epilepsia 2022;63:2911-2924.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Gataullina S, Galvani G, Touchet S, Nous C, et al. GluN2C selective inhibition is a target to develop new antiepileptic compounds. Epilepsia 2022;63:2911-2924.
PMID: 36054371